DoD Spinal Cord Injury Investigator-Initiated Research Award

The summary for the DoD Spinal Cord Injury Investigator-Initiated Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Spinal Cord Injury Investigator-Initiated Research Award: The SCIRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY09. Since then, 132 Investigator-Initiated Research Award applications have been received, and 25 have been recommended for funding. The IIRA is intended to support studies that have the potential to make an important contribution to SCI research and/or patient care. Projects should be innovative, address an Area of Encouragement, and impact the health care needs of military Service members, Veterans, and/or their family members and caregivers. All applications must specifically and clearly address the military relevance of the proposed research. Collaboration with military researchers and clinicians is encouraged. Research projects may focus on any phase of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial. Observations that drive a research idea may be derived from laboratory discovery, population-based studies, a clinician's first-hand knowledge of patients, or anecdotal data. Applications must include preliminary data that is relevant to SCI and the proposed project. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested with a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on clinical trials and clinical research, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the FY12 SCIRP Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-12-SCIRP-CTA).